Publications
Detailed Information
Effects of clozapine on behavioral sensitization induced by cocaine
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Hye-Jean | - |
dc.contributor.author | Cui, Feng Ji | - |
dc.contributor.author | Hwang, Jae Yeon | - |
dc.contributor.author | Kang, Ung Gu | - |
dc.date.accessioned | 2012-07-05T00:40:03Z | - |
dc.date.available | 2012-07-05T00:40:03Z | - |
dc.date.issued | 2010-01 | - |
dc.identifier.citation | PSYCHIATRY RESEARCH; Vol.175 1-2; 165-170 | ko_KR |
dc.identifier.issn | 0165-1781 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78522 | - |
dc.description.abstract | Using cocaine-sensitized mice as a model for psychosis. this study investigated whether subchronic treatment with clozapine could affect the sensitized state of the animals and examined the accompanying molecular changes in the brain. To induce sensitization, ICR mice (n = 44) were treated with cocaine for 5 days. After 7 days of withdrawal, sensitization was confirmed by a cocaine challenge. Then. the sensitized animals were treated with clozapine for 5 days and rechallenged with cocaine. The frontal cortices were removed from the mice (n = 16) 24 h after the last challenge, and the phosphorylation status of some key signaling molecules was investigated. Compared with the sensitized mice receiving the vehicle treatment, the sensitized mice receiving subchronic clozapine showed less locomotor activity, with an activity level similar to that of non-sensitized mice. However, clozapine did not directly affect the stimulatory effect of cocaine. Clozapine also reversed some of the sensitization-induced biochemical changes, including increased phosphorylation of GSK-3 beta and CREB, in the frontal cortex. Subchronic treatment with clozapine apparently de-sensitized the sensitized mice. The long-term effect of clozapine on stimulant-induced sensitization may be related to the therapeutic effect of the drug as an antipsychotic agent. Crown Copyright (C) 2008 Published by Elsevier Ltd. All fights reserved. | ko_KR |
dc.description.sponsorship | This study was supported by a grant (No. 04-2006-041-0) from the Seoul National
University Hospital Research Fund, Republic of Korea. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER IRELAND LTD | ko_KR |
dc.subject | AKT | ko_KR |
dc.subject | Cocaine | ko_KR |
dc.subject | Cyclic AMP response element binding protein | ko_KR |
dc.subject | Clozapine | ko_KR |
dc.subject | Behavioral sensitization | ko_KR |
dc.subject | ERK | ko_KR |
dc.subject | Prefrontal cortex | ko_KR |
dc.subject | Psychosis | ko_KR |
dc.subject | Glycogen synthase kinase-3 | ko_KR |
dc.title | Effects of clozapine on behavioral sensitization induced by cocaine | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 박혜진 | - |
dc.contributor.AlternativeAuthor | 황재연 | - |
dc.contributor.AlternativeAuthor | 강웅구 | - |
dc.identifier.doi | 10.1016/j.psychres.2008.10.005 | - |
dc.citation.journaltitle | PSYCHIATRY RESEARCH | - |
dc.description.citedreference | Featherstone RE, 2007, PROG NEURO-PSYCHOPH, V31, P1556, DOI 10.1016/j.pnpbp.2007.08.025 | - |
dc.description.citedreference | Fumagalli F, 2007, EUR J NEUROSCI, V26, P2756, DOI 10.1111/j.1460-9568.2007.05918.x | - |
dc.description.citedreference | Ago Y, 2007, SYNAPSE, V61, P757, DOI 10.1002/syn.20421 | - |
dc.description.citedreference | Chen PC, 2007, J NEUROCHEM, V100, P225, DOI 10.1111/j.1471-4159.2006.04203.x | - |
dc.description.citedreference | McDaid J, 2006, MOL PHARMACOL, V70, P2064, DOI 10.1124/mol.106.023051 | - |
dc.description.citedreference | Zhang ZJ, 2006, SCHIZOPHR RES, V88, P102, DOI 10.1016/j.schres.2006.07.010 | - |
dc.description.citedreference | Seeman P, 2006, SYNAPSE, V60, P319, DOI 10.1002/syn.20303 | - |
dc.description.citedreference | Ago Y, 2006, PHARMACOL BIOCHEM BE, V85, P198, DOI 10.1016/j.pbb.2006.07.036 | - |
dc.description.citedreference | Valjent E, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-20 | - |
dc.description.citedreference | Zhang XW, 2006, BIOCHEM BIOPH RES CO, V340, P1144, DOI 10.1016/j.bbrc.2005.12.114 | - |
dc.description.citedreference | Brenhouse HC, 2006, NEUROSCIENCE, V137, P773, DOI 10.1016/j.neuroscience.2005.09.039 | - |
dc.description.citedreference | Radwanska K, 2005, EUR J NEUROSCI, V22, P939, DOI 10.1111/j.1460-9568.2005.04286.x | - |
dc.description.citedreference | STEKETEE JD, 2005, CRIT REV NEUROBIOL, V17, P69 | - |
dc.description.citedreference | Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031 | - |
dc.description.citedreference | Pozzi L, 2003, J NEUROCHEM, V86, P451, DOI 10.1046/j.1471-4159.2003.01851.x | - |
dc.description.citedreference | Roh MS, 2003, PROG NEURO-PSYCHOPH, V27, P1 | - |
dc.description.citedreference | Davidson C, 2002, EUR J PHARMACOL, V453, P255 | - |
dc.description.citedreference | Filip M, 2001, J PHYSIOL PHARMACOL, V52, P471 | - |
dc.description.citedreference | Ruiu S, 2000, MOL PSYCHIATR, V5, P673 | - |
dc.description.citedreference | Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99 | - |
dc.description.citedreference | Laruelle M, 2000, BRAIN RES REV, V31, P371 | - |
dc.description.citedreference | WIESBECK GA, 2000, ALCOHOL ALCOHOLISM, V35, P394 | - |
dc.description.citedreference | Li Y, 1999, SYNAPSE, V34, P169 | - |
dc.description.citedreference | Yui K, 1999, MOL PSYCHIATR, V4, P512 | - |
dc.description.citedreference | Meng Z, 1998, MOL BRAIN RES, V61, P39 | - |
dc.description.citedreference | PANKSEPP J, 1998, SEEKING SYSTEMS ANTI, P144 | - |
dc.description.citedreference | Pierce RC, 1997, BRAIN RES REV, V25, P192 | - |
dc.description.citedreference | Lieberman JA, 1997, NEUROPSYCHOPHARMACOL, V17, P205 | - |
dc.description.citedreference | Pierce RC, 1997, J NEUROSCI, V17, P3254 | - |
dc.description.citedreference | Mattingly BA, 1996, PHARMACOL BIOCHEM BE, V53, P481 | - |
dc.description.citedreference | ESSMAN WD, 1994, PHARMACOL BIOCHEM BE, V49, P107 | - |
dc.description.citedreference | PILOTTE NS, 1994, J PHARMACOL EXP THER, V269, P963 | - |
dc.description.citedreference | TELLA SR, 1994, PHARMACOL BIOCHEM BE, V48, P151 | - |
dc.description.citedreference | REIMER AR, 1994, PSYCHOPHARMACOLOGY, V113, P404 | - |
dc.description.citedreference | ROBINSON TE, 1993, BRAIN RES REV, V18, P247 | - |
dc.description.citedreference | SATEL SL, 1991, AM J PSYCHIAT, V148, P1708 | - |
dc.description.citedreference | TERWILLIGER RZ, 1991, BRAIN RES, V548, P100 | - |
dc.description.citedreference | STRAUSS WH, 1991, EUR NEUROPHARMACOL, V1, P101 | - |
dc.description.citedreference | CALLIGARO DO, 1987, MEMBRANE BIOCHEM, V7, P87 | - |
dc.description.citedreference | SATO M, 1983, BIOL PSYCHIAT, V18, P429 | - |
dc.description.citedreference | POST RM, 1976, NATURE, V260, P731 | - |
dc.description.citedreference | ROBERTS DCS, 1975, BRAIN RES, V93, P441 | - |
dc.description.tc | 3 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.